SCYNEXIS, Inc. (LON:0L49)
0.8321
+0.0298 (3.71%)
At close: Oct 15, 2025
SCYNEXIS Market Cap
SCYNEXIS has a market cap or net worth of 23.62 million as of October 17, 2025. Its market cap has decreased by -42.12% in one year.
Market Cap
23.62M
Enterprise Value
-8.03M
Revenue
2.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.83
Market Cap Chart
Since May 2, 2014, SCYNEXIS's market cap has decreased from 45.09M to 23.62M, a decrease of -47.61%. That is a compound annual growth rate of -5.48%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 17, 2025 | 23.62M | -35.60% |
Dec 31, 2024 | 36.68M | -43.69% |
Dec 29, 2023 | 65.14M | 54.06% |
Dec 30, 2022 | 42.28M | -67.09% |
Dec 31, 2021 | 128.48M | 18.93% |
Dec 31, 2020 | 108.03M | 61.66% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 194.68B |
HSBC Holdings | 170.04B |
Shell | 155.14B |
Unilever | 114.27B |
Rolls-Royce Holdings | 95.96B |
Rio Tinto Group | 87.63B |
British American Tobacco p.l.c. | 83.30B |
GSK plc | 65.72B |